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Abstract
Background To ensure adequate intensive care unit (ICU) capacity for SARS-CoV-2 patients, elective neurosurgery and neu-
rosurgical ICU capacity were reduced. Further, the Finnish government enforced strict restrictions to reduce the spread. Our
objective was to assess changes in ICU admissions and prognosis of traumatic brain injury (TBI) and aneurysmal subarachnoid
hemorrhage (SAH) during the Covid-19 pandemic.
Methods Retrospective review of all consecutive patients with TBI and aneurysmal SAH admitted to the neurosurgical ICU in
Helsinki from January toMay of 2019 and the samemonths of 2020. The pre-pandemic time was defined as weeks 1–11, and the
pandemic time was defined as weeks 12–22. The number of admissions and standardized mortality rates (SMRs) were compared
to assess the effect of the Covid-19 pandemic on these. Standardized mortality rates were adjusted for case mix.
Results Two hundred twenty-four patients were included (TBI n = 123, SAH n = 101). There were no notable differences in case
mix between TBI and SAH patients admitted during the Covid-19 pandemic compared with before the pandemic. No notable
difference in TBI or SAH ICU admissions during the pandemic was noted in comparison with early 2020 or 2019. SMRs were no
higher during the pandemic than before.
Conclusion In the area of Helsinki, Finland, there were no changes in the number of ICU admissions or in prognosis of patients
with TBI or SAH during the Covid-19 pandemic.
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Introduction
The Covid-19 pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), prompted unprece-
dented restriction measures to prevent the spread of the virus.
In hospitals, major reorganizations, including reschooling of
healthcare professionals and reallocation of medical supplies,
took place to be able to tackle the expected sharp rise in
SARS-CoV-2 infected patients. Also, neurosurgery was af-
fected, as non-emergent surgeries were postponed, and outpa-
tient clinic visits cancelled [19]. Accordingly, there were con-
cerns that the diagnosis and treatment of other illnesses requir-
ing intensive care might suffer due to the sudden and massive
reallocation in intensive care resources [16]. However, a pre-
vious European survey study suggested a lower number of
treated aneurysmal subarachnoid hemorrhage (SAH) and trau-
matic brain injury (TBI) patients during the pandemic [11].
Yet, a study from Charité, Berlin, did not find any change in
the number of aneurysmal SAH or TBI admissions compared
previous years.
In Finland, the first wave of Covid-19 hit the Helsinki area
the worst. Thus, we saw the closing of borders, restrictions of
free movement, and the closing of schools and restaurants
under the enforcement of the Emergency Powers Act.
Consequently, the incidence of SARS-CoV-2 infection and,
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thus its imposed burden on the healthcare system, remained
relatively low and our capacity to care for emergency neuro-
surgical cases remained good.
Our aim was to give a detailed description regarding ad-
missions and outcomes of patients with TBI and aneurysmal
SAH treated in the neurosurgical ICU in Helsinki during the
Covid-19 pandemic. Further, we report changes in emergency
and non-emergency neurosurgical operations during this peri-
od. We hypothesized a decrease in the occurrence of TBIs due
to strict regulations limitingmovement and travel in the region
but a similar occurrence of aneurysmal SAH compared with
the previous year.
Methods
We reviewed all consecutive cases admitted due to aneurys-
mal SAH or TBI to the neurosurgical ICU of Helsinki
University Hospital between 1 January and 31 May 2020
and between 1 January and 31 May 2019. The 2019 period
was used as a reference for 2020. As of 2019, the neurosurgi-
cal department in Helsinki covers a population of approxi-
mately 2.2 million people, of which 1.8 million (82%) are
18 years or older (the catchment area expanded between
2018 and 2019). We included only adults (18 years or older),
as children are treated at a different location (Children’s
Hospital, Helsinki). In the region of Helsinki and Uusimaa
(referred to as the HUS area), treatment of TBIs and SAHs
that require intensive care has for decades been centralized at
the neurosurgical department in Helsinki. Essentially, all pa-
tients with aneurysmal SAH admitted to the hospital are trans-
ferred to our unit (with the possible exception of patients first
admitted to other hospitals that are deemed to have a dire
prognosis not benefi t t ing from neurosurgical or
neurointensive care) [7]. Regarding TBIs, patients with severe
TBI and those requiring neurosurgical care are transferred to
our unit [10]. Patients with moderate-to-mild TBI not requir-
ing neurosurgical or neurointensive care are not regularly ad-
mitted to our unit and may be treated at local hospitals accord-
ing to ability and capacity.
Major Covid-19 restrictions in Finland
As of 17 March 2020 (week 12), the Emergency Powers Act
was enforced in Finland. To prevent the spread of SARS-
CoV-2, between 27 March (end of week 13) and 15 April
(middle of week 16) 2020, travel in and out of the region of
Helsinki and Uusimaa (population 1.7 million) was prohibited
(with the exception of hospital transfers and work- or family-
related travel; i.e., the restrictions applied mainly to leisure-
related travel). Of importance, hospitals situated outside the
Uusimaa border but still belonging to the catchment area of
Helsinki University Hospital transferred patients requiring
neurointensive or neurosurgical care normally. From 3 April
(end of week 14) to 31 May (end of week 22), all restaurants,
cafes, and bars were closed. From 18 March (middle of week
12) to 14 May (middle of week 20), schools were closed
At the end ofMarch, the Joint Authority of the Helsinki and
Uusimaa Hospital District started to decrease non-urgent treat-
ment with the goal of doubling current ICU capacity to treat
SARS-CoV-2 patients.
Statistical analyses
The frequency of TBI and aneurysmal SAH admissions (sep-
arately and jointly) are presented in a stepwise fashion, in-
creasing every week, and as the raw number of admissions
every 2 weeks. The number of emergency operations is shown
on a weekly basis. The number of SARS-CoV-2 treated in the
ICUs in HUS was reported twice a week and is shown as the
cumulative number of patients receiving intensive care at that
time.
Week 12 was defined as the cut-off, as extended measures
for stopping the spread were implemented following the en-
forcement of the Emergency Powers Act. Thus, we divided
the patients into two intervals—the early interval includes
weeks 1–11 (in 2019, 1 January to 17 March; in 2020, 1
January to 15 March) and the late interval includes weeks
12–22 (in 2019, 18 March to 31 May; in 2020, 16 March to
31 May).
We report the number of admitted TBI and SAH patients
tested for SARS-CoV-2 in 2020. The test was carried out with
most unconscious patients whose background information
could not rule out SARS-CoV-2.
We used the 30-day all-cause mortality as the primary pa-
tient outcome of interest. We assessed standardized mortality
rates (SMR) for eachmonth and interval. The predicted risk of
30-day mortality was calculated using multivariable logistic
regression, accounting for age (as a continuous variable),
Glasgow Coma Scale (GCS as a continuous variable, also
presented as categories 3–8, 9–12, and 13–15) score on ad-
mission (or last reliable assessment before intubation and se-
dation), and admission pupillary light reactivity (categories:
normal, abnormal). The predicted risk-of-death model was
based upon patients admitted in 2019 and tested on patients
admitted in 2020. The performance of the model is given as
the area under the curve (AUC) of the receiver operating char-
acteristic with 95% confidence interval (CI). SMRs are com-
pared using a t test.
All neurosurgical non-emergency and emergency surgeries
and neurosurgical endovascular procedures performed during
the same periods were anonymously extracted by a surgical
manager software program (Centricity™ Opera, GE
Healthcare, Chicago, Ill, USA) and the Picture Archiving
and Communication System software (Siemens Syngo,
Siemens Healthineers, Erlangen, Germany).
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The study is part of the ongoing quality control project of
brain injury patients treated at our neurosurgical intensive care
unit. The research committee of Helsinki University Hospital
approved our quality control project and waived the need for
informed consent (HUS/26/2018 §134).
Results
The total study population consisted of 224 patients (105 ad-
mitted in 2019 and 119 admitted in 2020). Patient character-
istics according to admission year are shown in Table 1. Of all
patients, 123 (55%) were TBI patients and 101 (45%) were
SAH patients. There were no notable differences in diagnoses
(TBI vs. SAH), interval (early vs. late), age, sex, GCS score,
pupillary light reaction, and ICU length-of-stay between the
2019 and the 2020 admissions. There were no notable differ-
ences in patient characteristics for TBI or SAH patients admit-
ted in 2019 and 2020 (Table 2). For SAH patients, there were
no differences between those admitted in the early and late
intervals in 2020 (Table 3). TBI patients admitted in the late
interval in 2020 underwent craniotomy or decompressive
craniectomy less frequently than patients admitted in the early
interval (61 vs. 35%, p = 0.038). In total, 24 patients (11 TBI
and 13 SAH patients) were tested for SARS-CoV-2, none
being positive.
Admissions and operations
In comparison with 2019, no major changes in the number of
admissions were seen in 2020 on a biweekly basis (Fig. 1).
Inspection of the cumulative number of admissions revealed a
minor difference between 2019 and 2020, indicating a mini-
mal increase in 2020 (Fig. 2).
The number of emergency operations decreased after week
10 (Fig. 3), concurrent with the peak in the number of ICU-
treated SARS-CoV-2 patients in Helsinki. Simultaneously, a
major decrease in elective surgeries was noted.
Mortality
The AUC of the predicted risk of death model was 0.88 (95%
CI, 0.82–0.94), including all TBI and SAH patients admitted
in 2020. For TBI patients admitted in 2020, the AUCwas 0.85
(95% CI, 0.76–0.94), and in SAH patients admitted in 2020,
the AUCwas 0.90 (95%CI, 0.81–0.98). There was no notable
difference in SMRs (Fig. 4) for patients treated in the early and
late intervals in 2020 compared with 2019 for any of the
patient groups (p > 0.05 for all comparisons).
Table 1 Patient characteristics
per year of admission Variable 2019 (n = 105) 2020 (n = 119) p value
Diagnosis
TBI 56 (53%) 67 (56%) 0.656
SAH 49 (47%) 52 (44%)
Interval
Early 53 (50%) 61 (51%) 0.907
Late 52 (50%) 58 (49%)
Age (median (IQR)) 50 (62, 72) 56 (44, 71) 0.163
Female (n (%)) 44 (42%) 45 (38%) 0.533
GCS score (n (%))
3–8 39 (37%) 37 (31%) 0.480
9–12 18 (17%) 18 (15%)
13–15 48 (46%) 64 (54%)
Pupillary light reaction (n (%))
Normal 87 (83%) 95 (80%) 0.563
Abnormal 18 (17%) 24 (20%)
Days in ICU (median (IQR)) 5 (3, 9) 5 (2, 12) 0.988
SARS-CoV-2 testeda (n (%)) NA 24 (20%) NA
SARS-CoV-2 positiveb (n (%)) NA 0 (0%) NA
Early interval includes weeks 1 to 11 and late interval includes weeks 12 to 22
Abbreviation:GCS, Glasgow Coma Scale; ICU, intensive care unit; TBI, traumatic brain injury; SAH, aneurysmal
subarachnoid hemorrhage
a Tested during the initial admission
bOf tested
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Discussion
We found that the number of TBI and aneurysmal SAH patients
admitted to the neuro-ICU stayed the same during the Covid-19
pandemic compared with the previous year. Furthermore, we
did not see any increase in risk of death related to TBI or SAH.
The number of emergency and non-emergency neurosurgical
operations was lower during the Covid-19 outbreak compared
with the same timeframe in 2019.
Although the first SARS-CoV-2 infection was reported in
Finland in January 2020 when a foreign tourist tested positive,
it was not until March 2020 that the number of positive-tested
SARS-CoV-2 patients began to rapidly increase. The first do-
mestic SARS-CoV-2 case was on 26 February 2020, having
contracted the infection from northern Italy. We began seeing
a notable increase in the number of patients requiring intensive
care due to SARS-CoV-2 in the beginning of March with a
peak reached soon after the Uusimaa province’s lockdown
and closing of restaurants in early April.
Thus, the first Covid-19 wave hit Finland later than some
other countries in Europe, providing extra time to prepare the
healthcare system. The operative plan and required procedures
to increase ICU capacity were performed efficiently and
promptly, which guaranteed sufficient ICU capacity through-
out the Covid-19 outbreak, not only to treat SARS-CoV-2
patients but also to treat other patients requiring intensive care.
Regarding neurosurgical care in Helsinki, the number of
neuro-ICU beds and the number of elective neurosurgerywere
reduced and specialized neuro-ICU nurses were reallocated to
Covid-19-specific ICUs. Still, it was decided that the neuro-
ICU was only to treat Covid-19 patients if all other resources
have been used. This decision ensured adequate priority and
resources to care for emergency neurosurgical patients.
Reductions in elective neurosurgery have been reported
throughout Europe, resulting in prolonged waiting times for
elective surgery [9, 11]. As reported by Mathiesen et al., large
variations in the magnitude of resource reallocation (neuro-
ICU, capacity, ORs, beds) throughout Europe were noted
Table 2 Patient characteristics per disease group and year of admission
Variable Disease group
TBI (n = 123) SAH (n = 101)
2019 (n = 56) 2020 (n = 67) p value 2019 (n = 49) 2020 (n = 52) p value
Interval
Early 31 (55%) 33 (49%) 0.500 22 (45%) 28 (54%) 0.369
Late 25 (45%) 34 (51%) 27 (55%) 24 (26%)
Age (median (IQR)) 63 (54, 72) 60 (41, 72) 0.416 58 (49, 70) 55 (48, 67) 0.394
Female (n (%)) 13 (23%) 13 (19%) 0.606 31 (63%) 32 (62%) 0.858
GCS score (n (%))
3–8 22 (39%) 21 (31%) 0.402 17 (35%) 16 (31%) 0.901
9–12 14 (25%) 14 (21%) 4 (8%) 4 (8%)
13–15 20 (36%) 32 (48%) 28 (57%) 32 (61%)
Pupillary light reaction (n (%))
Normal 45 (80%) 58 (87%) 0.353 42 (86%) 37 (71%) 0.076
Abnormal 11 820%) 9 (13%) 7 (14%) 15 (29%)
TBI operative treatment
Craniotomy or decompressive craniectomy 31 (55%) 32 (47%) 0.401 NA NA NA
Aneurysm treatment
Endovascular NA NA NA 26 (53%) 38 (73%) 0.111
Microsurgical NA NA NA 14 (29%) 9 (17%)
No treatmenta NA NA NA 9 (18%) 5 (10%)
Days in ICU (median (IQR)) 4 (2, 7) 3 (2, 8) 0.869 8 (4, 14) 9 (3, 13) 0.923
SARS-CoV-2 testedb (n (%)) NA 11 (16%) NA NA 13 (25%) NA
SARS-CoV-2 positivec (n (%)) NA 0 (0%) NA NA 0 (0%) NA
Abbreviation: GCS, Glasgow Coma Scale; TBI, traumatic brain injury; SAH, aneurysmal subarachnoid hemorrhage
a In all cases aneurysm treatment was withheld due to dismal prognosis
b Tested during the initial admission
c Of SARS-CoV-2 tested
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[11]. Still, it seems that most of the units across Europe have
been able to provide adequate treatment for neurosurgical
emergency patients. In Helsinki, we did not end up in a situ-
ation where patient flow (of SARS-CoV-2 and non-SARS-
CoV-2 patients) would have pushed the limits of our treatment
capacity. Thus, any out of the normal ethical triage was not
needed [8].
Interestingly, none of the TBI and aneurysmal SAH pa-
tients tested positive during the study period nor were there
any known cases of TBI or aneurysmal that would not have
been admitted due to SARS-CoV-2. Of note is that the local
testing policy was that unconscious patients, in whom a of
history SARS-CoV-2 symptoms could not be ruled out, were
tested and isolated until negative results.
While the focus was to secure sufficient healthcare
capacity to treat Covid-19 patients, there were concerns
that the diagnosis and treatment of other acute diseases
might suffer. Possible reasons for this could include a
higher threshold for contacting healthcare services among
the general population due to fear of contracting Covid-
19 or acute diseases being left unnoticed due to the
effects of social distancing [16]. In fact, hospital admis-
sions due to transient ischemic attack (TIA), acute
stroke, and acute coronary syndrome decreased during
the Covid-19 pandemic [3, 4, 6]. Also, one report indi-
cates that time from stroke onset to hospital arrival was
prolonged during the pandemic [17]. However, in con-
trast with TIA or milder forms of ischemic stroke, the
symptoms of aneurysmal SAH are often so severe that
delaying contact with healthcare seems unlikely.
According to our hypothesis, we found that the number
of neuro-ICU-admitted aneurysmal SAH stayed largely
the same in 2019 and 2020. In retrospect, one could have
argued that the aneurysmal SAH incidence would de-
crease due to the collapse in incidence of the normal
seasonal influenza epidemic [18] as it has been speculat-
ed that respiratory infections might predispose aneurysm
rupture [2, 14]. In fact, in a large European survey study,
13 out of 25 centers reported a lower number of ICU-
treated SAH patients during the Covid-19 pandemic [11].
Whether this is due to the lower rate of seasonal influ-
enza or due to other reasons remains open.
Table 3 Patient characteristics per disease group according to 2020 time epoch
Variable Disease group
TBI (n = 67) SAH (n = 52)
Early (n = 33) Late (n = 34) p value Early (n = 28) Late (n = 24) p value
Age (median (IQR)) 59 (43, 75) 62 (38, 71) 0.906 55 (46, 68) 55 (51, 65) 0.838
Female (n (%)) 7 (21%) 6 (18%) 0.712 14 (50%) 18 (75%) 0.065
GCS score (n (%))
3–8 9 (27%) 12 (35%) 0.175 9 (32%) 7 (29%) 0.967
9–12 10 (30%) 4 (12%) 2 (7%) 2 (8%)
13–15 14 (43%) 18 (53%) 17 (61%) 15 (63%)
Pupillary light reaction (n (%))
Normal 30 (91%) 28 (82%) 0.305 18 (64%) 19 (79%) 0.238
Abnormal 3 (9%) 6 (18%) 10 (36%) 5 (21%)
TBI operative treatment
Craniotomy or decompressive craniectomy 20 (61%) 12 (35%) 0.038 NA NA NA
Aneurysm treatment
Endovascular NA NA NA 20 (72%) 18 (74%) 0.605
Microsurgical NA NA NA 6 (21%) 3 (13%)
No treatmenta NA NA NA 2 (7%) 3 (13%)
Days in ICU (median (IQR)) 3 (2, 8) 3 (2, 8) 0.957 6 (3, 15) 10 (3, 13) 0.938
SARS-CoV-2 testedb (n (%)) 0 (0%) 11 (32%) NA 3 (11%) 10 (42%) NA
SARS-CoV-2 positivec (n (%)) NA 0 (0%) NA 0 (0%) 0 (0%) NA
Early interval includes weeks 1 to 11, and late interval includes weeks 12 to 22
Abbreviation: GCS, Glasgow Coma Scale; TBI, traumatic brain injury; SAH, aneurysmal subarachnoid hemorrhage
a In all cases aneurysm treatment was withheld due to dismal prognosis
b Tested during the initial admission
c Of SARS-CoV-2 tested
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In contrast with our hypothesis, we did not see a decline in
ICU admissions due to TBI during the heavy restrictions im-
posed in Finland. For example, in the European survey study,
18 out of 25 centers reported a lower number of ICU-treated
TBI patients. Thus, our finding was surprising, in part because
one would assume that self-isolation and closing of bars
would prevent head injuries, considering that over a third of
TBIs in Finland occur under the influence of alcohol [12]. Yet,
Fig. 1 Number of TBI (upper),
SAH (middle), and combined
(lower) admissions to the neuro-
surgical ICU on a biweekly basis.
Relevant Covid-19 pandemic
features shown
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Fig. 2 Cumulative number of
patients with TBI (upper), SAH
(middle), and combined (lower)
admitted to the neurosurgical
ICU. Relevant Covid-19 pan-
demic features shown
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the closing of restaurants and bars may have just shifted the
place of alcohol consumption, as alcohol sales reported by the
state-owned Alko Inc. (the national alcoholic beverage retail
monopoly in Finland, controlling the trade and sale of alco-
holic beverages > 5.5%) increased [1]. This seems plausible
considering that half to two-thirds of all TBIs treated in
the neuro-ICU are low-energy fall [13]. For example,
the number of people injured in traffic accidents during
January to May 2020 decreased by 25% compared with
the same period in 2019, although the number of deaths
Fig. 3 Number of patients with
SARS-CoV-2 treated in intensive
care units in the Helsinki and
Uusimaa area (upper), number of
emergency neurosurgical opera-
tions (middle), and number of
non-emergency neurosurgical op-
erations (lower). Operations
shown for 2019 (red) and 2020
(blue). Relevant Covid-19 pan-
demic features shown
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due to traffic accidents remained unchanged (data from
Statistics Finland) [15]. Thus, it seems there was a re-
duction in the number of milder injuries due to the
lockdown, but the number of severe injuries stayed the
same.
Similar to our findings, Hecht and coworkers from Berlin
reported a decline in all neuro-emergencies at the Charité
University Hospital during the Covid-19 pandemic. They spe-
cifically reported a no change in the number of aneurysmal
SAH and TBI admissions [5].
Although the restrictions did not affect the rate of ICU
admissions, we had temporarily fewer emergency operations
during the lockdown. Also, the number of emergency
craniotomies for TBI declined between the early and late in-
tervals of 2020. However, an overall reduction in emergency
operations was also seen in 2019 and may be related to normal
seasonal variation instead of Covid-19. As expected, the rate
of elective operations declined following the decision to cut
non-urgent treatment.
Conclusions
The strict nationwide restrictions enforced in Finland due to
the Covid-19 pandemic did not result in a notable drop in the
number of neuro-ICU-treated TBI or aneurysmal SAH
Fig. 4 Standardized mortality
rates (SMR) with 95% CI ac-
cording to time interval for pa-
tients with traumatic brain injury
(upper), subarachnoid hemor-
rhage (middle), and combined
(lower). SMRs are calculated as
30-day mortality. The expected
risk of 30-day mortality is adjust-
ed for age, Glasgow Coma Scale
score on admission, and pupillary
light reactivity. SMRs are com-
pared using a t test
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patients. We did not find evidence of worse prognoses in TBI
and SAH patients during the Covid-19 pandemic.
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